Aurinia Pharmaceuticals Inc.
AUPH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001600620
In the last 90 days, Aurinia Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 282 institutions reported holding it in 13F filings for Q2 2026, worth $1.34B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Aurinia Pharmaceuticals Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 198
- +1 vs. Q2 2023
- Shares held
- 50.9M
- +537.0K (+1.1%) vs. Q2 2023
- Total value
- $395.2M
- −$92.2M (−18.9%) vs. Q2 2023
- New holders
- 24
- 69 more added
- Sold out
- 23
- 49 more reduced
3 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AUPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 282 | $1.34B |
| Q1 2026 | 260 | $1.10B |
| Q4 2025 | 256 | $1.15B |
| Q3 2025 | 242 | $729.8M |
| Q2 2025 | 219 | $497.1M |
| Q1 2025 | 214 | $504.1M |
| Q4 2024 | 200 | $525.4M |
| Q3 2024 | 183 | $428.9M |
| Q2 2024 | 171 | $319.9M |
| Q1 2024 | 178 | $280.8M |
| Q4 2023 | 191 | $485.4M |
| Q3 2023 | 198 | $395.2M |
| Q2 2023 | 200 | $487.5M |
| Q1 2023 | 186 | $553.5M |
| Q4 2022 | 192 | $223.1M |
| Q3 2022 | 189 | $420.5M |
| Q2 2022 | 199 | $509.9M |
| Q1 2022 | 184 | $532.9M |
| Q4 2021 | 191 | $895.1M |
| Q3 2021 | 167 | $966.8M |
| Q2 2021 | 167 | $640.9M |
| Q1 2021 | 170 | $682.5M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Aurinia Pharmaceuticals Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Liontrust Investment Partners LLP | 0 | $0 | 0.00% | −421,000−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −241,740−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −168,595−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −150,633−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −65,500−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −39,733−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −29,675−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −25,038−100.0% | Sold out |
| American Century Companies Inc | 0 | $0 | 0.00% | −24,807−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −23,391−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −22,941−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −19,100−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,795−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −15,395−100.0% | Sold out |
| Visionary Wealth Advisors | 0 | $0 | 0.00% | −12,700−100.0% | Sold out |
| Wolverine Trading, LLC | 0 | $0 | 0.00% | −13,220−100.0% | Sold out |
| Shell Asset Management Co | 0 | $0 | 0.00% | −9,965−100.0% | Sold out |
| Focused Wealth Management, Inc | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −4,500−100.0% | Sold out |
| Fiduciary Alliance LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −316−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |
| Piershale Financial Group, Inc. | – | – | – | – | Not filed |
| Coastal Capital Group, Inc. | – | – | – | – | Not filed |